These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 24572206

  • 1. Stopping anti-TNF agents in patients with Crohn's disease in remission: is it a feasible long-term strategy?
    Sorrentino D, Nash P, Viladomiu M, Hontecillas R, Bassaganya-Riera J.
    Inflamm Bowel Dis; 2014 Apr; 20(4):757-66. PubMed ID: 24572206
    [No Abstract] [Full Text] [Related]

  • 2. Normalization of mucosal cytokine gene expression levels predicts long-term remission after discontinuation of anti-TNF therapy in Crohn's disease.
    Rismo R, Olsen T, Cui G, Paulssen EJ, Christiansen I, Johnsen K, Florholmen J, Goll R.
    Scand J Gastroenterol; 2013 Mar; 48(3):311-9. PubMed ID: 23302000
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Infliximab as a bridge to remission maintained by antimetabolite therapy in Crohn's disease: A retrospective study.
    Chauvin A, Le Thuaut A, Belhassan M, Le Baleur Y, Mesli F, Bastuji-Garin S, Delchier JC, Amiot A.
    Dig Liver Dis; 2014 Aug; 46(8):695-700. PubMed ID: 24893686
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Trough s-infliximab and antibodies towards infliximab in a cohort of 79 IBD patients with maintenance infliximab treatment.
    Marits P, Landucci L, Sundin U, Davidsdottir L, Nilsson J, Befrits R, Wikström AC, Eberhardson M.
    J Crohns Colitis; 2014 Aug; 8(8):881-9. PubMed ID: 24486178
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Infliximab-induced psoriasis during therapy for Crohn's disease.
    Steinwurz F, Denadai R, Saad-Hossne R, Queiroz ML, Teixeira FV, Romiti R.
    J Crohns Colitis; 2012 Jun; 6(5):610-6. PubMed ID: 22398095
    [Abstract] [Full Text] [Related]

  • 9. Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation.
    Bortlik M, Duricova D, Machkova N, Hruba V, Lukas M, Mitrova K, Romanko I, Bina V, Malickova K, Kolar M, Lukas M.
    Scand J Gastroenterol; 2016 Jun; 51(2):196-202. PubMed ID: 26329773
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of outcomes parameters for induction of remission in new onset pediatric Crohn's disease: evaluation of the porto IBD group "growth relapse and outcomes with therapy" (GROWTH CD) study.
    Levine A, Turner D, Pfeffer Gik T, Amil Dias J, Veres G, Shaoul R, Staiano A, Escher J, Kolho KL, Paerregaard A, Martin de Carpi J, Veereman Wauters G, Koletzko S, Shevah O, Finnby L, Sladek M.
    Inflamm Bowel Dis; 2014 Feb; 20(2):278-85. PubMed ID: 24390062
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F, Portela F.
    BioDrugs; 2010 Dec 14; 24 Suppl 1():3-14. PubMed ID: 21175228
    [Abstract] [Full Text] [Related]

  • 15. Infliximab-induced thrombocytopenia in an elderly patient with ileocolonic Crohn's disease.
    Mocciaro F, Russo G, Di Mitri R, Marino A.
    Inflamm Bowel Dis; 2013 Dec 14; 19(4):E52-3. PubMed ID: 22535599
    [No Abstract] [Full Text] [Related]

  • 16. Prevention and treatment of postoperative Crohn's disease recurrence with anti-TNF therapy: a meta-analysis of controlled trials.
    Carla-Moreau A, Paul S, Roblin X, Genin C, Peyrin-Biroulet L.
    Dig Liver Dis; 2015 Mar 14; 47(3):191-6. PubMed ID: 25488057
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Anti-TNF-α therapy for renal amyloid as a complication of Crohn's disease.
    Blackmur JP, Chapman FA, Bellamy CO, Save V, Plevris JN, Shand AG, Whitworth C, Dhaun N.
    QJM; 2014 Jan 14; 107(1):57-9. PubMed ID: 23681221
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.